the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010...

biohaven: "rimegepant pivotal phase 3 trial results -- conference call.". march 2010  (19).

the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate".